Navigation Links
AMD Global Telemedicine Increases Data Sharing Capabilities for Clinicians and Physicians with AGNES 3.1.0
Date:3/13/2013

Chelmsford, MA (PRWEB) March 13, 2013

AMD Global Telemedicine Inc. (AMD), the world’s leading supplier of medical technology for clinical telemedicine, announced today an upgrade to their AGNES software system that now offers users the ability to share data across multiple platforms, capture and share third-party medical documents, manually add vital signs, and simplifies enterprise infrastructure integration.

AGNES 3.1.0 is telemedicine device aggregation software that gathers and distributes medical device data in real time from a referring to remote consulting location. The latest release includes the following new features:

  • HL7 integration: expands the user’s ability to share the medical information across multiple patient record platforms.
  • Third-party document capturing: a universal data acquisition feature has been added to give clinicians the ability to bring in medical data generated from any external medical device or software program that has “print” functionality.
  • Manual vital signs data entry: in addition to the existing VSM features of ANGES, important medical data captured from external vital sign devices can now be manually entered into the session details.
  • LDAP (Lightweight Directory Access Protocol) support: simplifies the user experience by removing the need to remember multiple account names and passwords and easily integrates into the existing enterprise infrastructure.

“This latest release of AGNES was driven by our customers’ request to truly capture the entire story of the patient, as well as our commitment to continue to provide a solution they can depend on for their telemedicine programs”, commented Dan McCafferty, Vice President, Global Sales & Corporate Development, AMD Global Telemedicine. “The added features allow the doctors or healthcare providers to look at all the medical information in a single session instead of having to compile it together, and then running the risk of missing a critical piece of medical data” added McCafferty.

For more information about AGNES 3.1.0 including full release notes, a product demonstration or an existing product upgrade contact AMD Global Telemedicine at 1-866-511-0923.

About AMD Global Telemedicine Inc.

AMD Global Telemedicine, Inc. is a Telemedicine Encounter Management Systems (TEMS™) company and the worldwide leading supplier of telemedicine technology, devices, and application software for both live telemedicine and deferred consultations. AMD has over 7100 patient end-point installations in 91 countries and delivers preeminent telemedicine solution design, turnkey installation, and training for telemedicine programs across the globe. For more information on AMD Global Telemedicine, please visit http://www.amdtelemedicine.com.

###

Contact Information:
Keri Dostie
Marketing Manager
AMD Global Telemedicine
Tel: 978-937-9021

Read the full story at http://www.prweb.com/releases/2013/3/prweb10508744.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Canada should play a role in addressing the global cancer epidemic
3. Global cardiology leaders meet in Dubai
4. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
5. International breast health global summit will focus on supportive care and quality of life
6. Scientists rewrite rulebook on breast cancer in landmark global study
7. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
8. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
9. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
10. New study identifies how information technology is used to solve global health challenges
11. New global report says US lags behind 130 other nations in preterm birth rate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... ... offering treatments for patients with sleep apnea and TMJ disorders. These conditions are ... physical health. Dr. Rassouli provides personalized care to reduce the risk of these ...
(Date:1/19/2017)... ... ... Allegheny Health Network (AHN) officials today announced a bold new step to greatly ... in the greater Pittsburgh region. Starting January 23, patients who call AHN by 11 ... afternoon. , AHN is the first healthcare provider in the region ...
(Date:1/19/2017)... VA (PRWEB) , ... January 19, 2017 , ... Tribble ... services to the eastern Virginia region, is inaugurating a charity event to honor Chad ... , While on duty last year, Chad Phillip Dermyer and his fellow officers were ...
(Date:1/19/2017)... Antonio, TX (PRWEB) , ... January 19, 2017 , ... ... has for the fifth consecutive year donated money to the Triumph Over Kid Cancer ... A. Ragan was one of those children. James saw firsthand the effect of the ...
(Date:1/19/2017)... (PRWEB) , ... January 18, 2017 , ... The CHP ... driving during a rain storm by slowing down and increasing the space between themselves ... 40. Los Angeles based car accident attorney Raymond R. Hassanlou notes that, rain or ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Md. , Jan. 19, 2017 The U.S. ... treatment of Chronic Idiopathic Constipation (CIC) in adult patients. ... from chronic gastrointestinal disorders," said Julie Beitz , M.D., ... FDA,s Center for Drug Evaluation and Research. "With the availability ... most appropriate treatment for their condition." ...
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... LONDON , January 19, 2017 Incretin ... Sympathomimetics and Others The global anti-obesity drugs ... the first half of the forecast period and CAGR of 38.7% ... expected to grow at a CAGR of 32.8% from 2016 to ... million in 2021, and $24,063 million in 2027. ...
Breaking Medicine Technology: